1. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets
   Phuong Linh Nguyen et al, 2021, Biomolecules CrossRef
2. The Ph paradigm in cancer
   Tomas Koltai, 2020, European Journal of Clinical Nutrition CrossRef
3. Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis
   Suthipong Chujan et al, 2018, Biomedical Reports CrossRef
4. Old wine in new bottles: Drug repurposing in oncology
   Michał Antoszczak et al, 2020, European Journal of Pharmacology CrossRef
5. H2 antihistamines: May be useful for combination therapies in cancer?
   Nora A. Mohamad et al, 2024, Biochemical Pharmacology CrossRef
6. Resistance to antiangiogenic treatments: A review
   Tomas Koltai et al, 2022, Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy CrossRef
7. The Akt pathway in oncology therapy and beyond (Review)
   George Nitulescu et al, 2018, International Journal of Oncology CrossRef
8. Involvement of histamine H1 and H2 receptor inverse agonists in receptor's crossregulation
   Antonela Díaz Nebreda et al, 2019, European Journal of Pharmacology CrossRef
9. Anti-Cancer Potential of Some Commonly Used Drugs
   Pallavi Kumari et al, 2021, Current Pharmaceutical Design CrossRef
10. pH and electrolytes metabolism in prostate cancer
    Tomas Koltai et al, 2021, Prostate Cancer Metabolism CrossRef
11. Pharmacodynamic Modeling to Evaluate the Impact of Cimetidine, an OCT2 Inhibitor, on the Anticancer Effects of Cisplatin
    Hardik Mody et al, 2022, Cells CrossRef